These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1642741)

  • 1. [Therapeutic possibilities of sympathoadrenergic reactions during general anesthesia using sublingual application of glycerol trinitrate].
    Olthoff D; Vetter B; Lüdecke F; Deutrich C
    Anaesthesiol Reanim; 1992; 17(1):27-38. PubMed ID: 1642741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
    Jensen KM; Dahl JB
    Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patch.
    Santoro A; Rovati LC; Setnikar I; Caplain H; Gualano V
    Arzneimittelforschung; 2000 Sep; 50(9):779-85. PubMed ID: 11050693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate.
    Kelly EA; Ahmed RM; Horowitz JD
    Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
    Jensen KM; Mikkelsen S
    Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired nitroglycerin biotransformation in patients with chronic heart failure.
    Petersson M; Rundqvist B; Bennett BM; Adams MA; Friberg P
    Clin Physiol Funct Imaging; 2008 Jul; 28(4):229-34. PubMed ID: 18384624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of glycerol trinitrate on R-amplitude in patients with chronic ischemic heart disease].
    Teichmann W
    Z Kardiol; 1989; 78 Suppl 2():112-4; discussion 115-7. PubMed ID: 2511682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
    Lee FW; Salmonson T; Metzler CH; Benet LZ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioaequivalence of sublingual glycerol trinitrate. Bioavailability and haemodynamic effects after application of a fluorochlorohydrocarbons-dependent spray and a new pumping system.
    Huber T; Merz PG; Harder S; Rietbrock N
    Arzneimittelforschung; 1990 Dec; 40(12):1319-22. PubMed ID: 2128865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of glycerin trinitrate (nitroglycerin) after sublingual administration in patients with chronic ischemic heart disease].
    Blagodatskikh SV; Piotrovskiĭ VK; Metelits VI; Riabokon' OS; Martsevich SIu
    Farmakol Toksikol; 1987; 50(6):59-63. PubMed ID: 3125063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence evaluation of the metabolites 1,2 and 1,3-glyceryl dinitrate of two different glyceryl trinitrate patches after 12-h usage in healthy volunteers.
    Hutt V; Sauter K; Pabst G; Bonn R; Fritschi E
    Arzneimittelforschung; 1994 Dec; 44(12):1317-21. PubMed ID: 7848350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative pharmacology of glycerol-1-nitrate and glyceryl trinitrate in various species].
    Leitold M; Laufen H; Yeates RA
    Arzneimittelforschung; 1986 May; 36(5):814-21. PubMed ID: 3089233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycerol trinitrate (nitroglycerin) plasma concentrations achieved after application of transdermal therapeutic systems to healthy volunteers.
    Gerardin A; Gaudry D; Moppert J; Theobald W; Fankhauser P
    Arzneimittelforschung; 1985; 35(2):530-2. PubMed ID: 3922382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biologic availability and hemodynamic actions following administration of sublingual glycerol trinitrate. A new delivery system].
    Huber T; Merz PG; Harder S
    Arzneimittelforschung; 1991 Jul; 41(7):715-8. PubMed ID: 1772460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic reactions to local glyceryl trinitrate administration.
    Kounis NG; Zavras GM; Papadaki PJ; Soufras GD; Poulos EA; Goudevenos J; Alangoussis A; Antonakopoulos K; Frangides C; Peristeropoulou SA; Koutsojannis C
    Br J Clin Pract; 1996 Dec; 50(8):437-9. PubMed ID: 9039714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of glyceryl nitrates after oral administration of glyceryl trinitrate.
    Laufen H; Leitold M
    Arzneimittelforschung; 1988 Jan; 38(1):103-5. PubMed ID: 3130064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of injectable nitroglycerin on atheromatous coronary stenoses].
    Verdiere C; Drobinski G; Lechat P; Mezghani M; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1985 Jun; 78(6):853-60. PubMed ID: 3929714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pharmacology and pharmacokinetics of glycerol-2-nitrate].
    Leitold M; Laufen H; Yeates RA
    Arzneimittelforschung; 1987 Jun; 37(6):692-8. PubMed ID: 3117068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.